Notably, recent evidence suggests that APOA1 plays a pivotal role in linking MAFLD to cardiovascular disease and possesses multifaceted functions in anti-inflammation and anti-insulin resistance, surpassing the influence of HDL-c alone. This evidence concerns the gene APOA1 and Insulin resistance.